Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and the Risk of Cirrhosis in Patients with Chronic Hepatitis B—A Retrospective Cohort Study

BACKGROUND: Metabolic dysfunction-associated fatty liver disease (MAFLD) is a novel proposed concept that is being recognized worldwide. Both chronic hepatitis B (CHB) and MAFLD have been independently attributed to an increased risk of disease development to cirrhosis. However, it is still unclear...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qing-Xia, Xue, Jiao, Shi, Mei-Jie, Xie, Yu-Bao, Xiao, Huan-Ming, Li, Sheng, Lin, Ming, Chi, Xiao-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356614/
https://www.ncbi.nlm.nih.gov/pubmed/35942038
http://dx.doi.org/10.2147/DMSO.S369824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356614/
https://www.ncbi.nlm.nih.gov/pubmed/35942038
http://dx.doi.org/10.2147/DMSO.S369824

Ejemplares similares